BioSpace News Archive

Biotech Bay

JelloX Biotech Opens New Horizons for AI-Powered 3D Pathology

JelloX Biotech Inc., a Taiwan-based startup focused on cancer pathology, announced involvement with two new research breakthroughs that demonstrate expanded potential for its specialized technology combining 3D imaging and AI.

March 31, 2023
·
3 min read
BioMidwest

RAYUS Radiology Introduces New State-of-the-Art CT Scanner Utilizing Photon-Counting Technology

RAYUS Radiology has bolstered its line of high-end imaging technology solutions with the installation of the new NAEOTOM Alpha® CT scanner from Siemens Healthineers at its Palm Beach Gardens, Florida location – the first CT scanner of its kind serving patients in South Florida.

March 31, 2023
·
4 min read
Calliditas to participate in upcoming April 2023 investor conferences

Calliditas Therapeutics AB announced its management’s participation in the following investor conferences.

March 31, 2023
·
2 min read
PolyPid Announces Closing of Underwritten Public Offering, Including Full Exercise of Overallotment Option, and Concurrent Private Placement with $11.4 Million in Aggregate Gross Proceeds

PolyPid Ltd. announced the closing of an underwritten public offering of ordinary shares, no par value, with gross proceeds of approximately $7.1 million, which includes the full exercise of the underwriter’s option to purchase additional Ordinary Shares.

March 31, 2023
·
5 min read
BioMidwest

RAYUS Radiology Adds New Wide-Bore 3T MRI Scanner to Its Fleet of Industry-Leading Imaging Solutions

RAYUS Radiology announces the latest addition to its line of cutting-edge imaging solutions serving the state of Utah with the installation of a new MAGNETOM Lumina MRI scanner from Siemens Healthineers at its Redwood location in Taylorsville, Utah.

March 31, 2023
·
2 min read
Genetown

Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from ATLAS

Oxurion NV, announces the below information, following the issuance of 28,942,629 new ordinary shares on March 28, 2023, for a total amount of EUR 300,000, as the result of the conversion of 12 convertible bonds, pursuant to the Capital Commitment entered into with Atlas Special Opportunities, LLC.

March 31, 2023
·
5 min read
Business

Belite Bio to Host Webcast on April 3, 2023 to Discuss 2022 Full Year Financial Results

Belite Bio, Inc (NASDAQ: BLTE) will host a live webcast on Monday, April 3, 2023, at 4:30 p.m. Eastern time to discuss the Company’s financial results for the full year ended December 31, 2022, and provide a general business update.

March 31, 2023
·
1 min read
Drug Development

ABIONYX Pharma Announces Its Strategy in Ophthalmology and New Positive Preclinical Results for the Deployment of Two Innovative Technology Platforms: Apotherapy and Biovectorization

ABIONYX Pharma, (FR0012616852 - ABNX - PEA PME eligible) today announced today announced its strategy in ophthalmology and new positive preclinical results in two innovative technological platforms: apotherapy and biovectorisation.

March 31, 2023
·
2 min read
Genetown

Oxurion Publishes 2022 Annual Report

Oxurion NV a biopharmaceutical company developing next generation standard of care ophthalmic therapies, with clinical stage assets in vascular retinal disorders, published its annual report for the financial year 2022.

March 31, 2023
·
1 min read
Entera Bio Provides 2022 Corporate Milestones and Financial Results for the Year Ended December 31, 2022

Entera Bio Ltd., a leader in the development of orally delivered peptides and therapeutic proteins, announced a summary of 2022 corporate achievements and financial results for the year ended December 31, 2022.

March 31, 2023
·
11 min read